Europe

Venn Life Sciences acquires Medevol

Wednesday, December 11, 2013 11:23 AM

European CRO Venn Life Sciences has acquired Medevol, a CRO based in Northern Ireland, for a total maximum consideration of $1.1 million.

More... »

WIRB Copernicus Group

Centro Ricerche Cliniche di Verona receives new EUCROF early phase quality mark

Wednesday, December 11, 2013 11:17 AM

Centro Ricerche Cliniche di Verona (CRC), an early phase CRO, has become the first organization to be accredited under a new scheme of quality certification conducted by the European CROs Federation (EUCROF).

More... »


Johnson & Johnson Innovation establishes network of partnering offices

Monday, December 9, 2013 12:29 PM

Johnson & Johnson Innovation, London, has formed a network of partnering offices across U.K. life science clusters. The offices function as extensions of its London Innovation Center, to work with academics and entrepreneurs throughout the U.K. to identify early stage innovation and support the translation of research into new products for patients.

More... »

NIHR Clinical Research Network improves non-commercial study inclusion times

Monday, December 9, 2013 12:22 PM

The National Institute for Health Research (NIHR) Clinical Research Network has decreased the time it takes for studies funded by non-commercial organizations, such as charitable organizations and academic institutions, to be included in the NIHR Portfolio of research.

More... »

Almirall reorganizes in Europe, cuts 250 positions

Friday, December 6, 2013 12:57 PM

Pharmaceutical company Almirall has reorganized in Europe to optimize its portfolio potential. Pharmaceutical markets in Europe, particularly in Spain, have been affected in recent years by economically driven decisions made by various countries’ health authorities that have negatively affected the growth of those markets and the introduction and uptake of new products. 

More... »

New Scientific Panel for Health to be established under Horizon 2020

Wednesday, December 4, 2013 01:04 PM

The Alliance for Biomedical Research in Europe (Biomed Alliance), a consortium of 21 member organizations representing over 400,000 experts, welcomes the E.U.’s decision to create a Strategic Scientific Panel for Health within H2020 as a major step toward more targeted investment in health innovation in Europe. The panel was voted in by the European Parliament in Strasbourg after lengthy negotiations on the overall H2020 proposal, which will run from 2014 to 2020.

More... »

Industry responds to European clinical trials regulation revision

Monday, December 2, 2013 01:09 PM

There is an increasing international competition in clinical trials because clinical research creates jobs, drives academic excellence and delivers innovative medicines for patients. Improving the attractiveness and competitiveness of Europe as a prime location for clinical research was a key driver for the revision of the E.U. clinical trial legislation, which aimed to reduce unnecessary red tape whilst preserving the quality and safety of clinical trials.

More... »

Funding promotes new tools and services in synthetic biology

Monday, December 2, 2013 01:01 PM

Businesses are being invited to develop standard tools and services that will help grow the emerging industry of synthetic biology. Up to $5.1 million is being made available by the Technology Strategy Board, together with the Biotechnology and Biological Sciences Research Council (BBSRC), the Engineering and Physical Sciences Research Council (EPSRC) and the Welsh Government.

More... »

Patient involvement increases public confidence in health research studies

Wednesday, November 27, 2013 10:58 AM

An Ipsos MORI survey of 1,295 British adults has shown that public confidence in health research studies can be increased by knowing that patients have participated in advising on the design of the study.

More... »

Boston Scientific system receives CE Mark approval for Dystonia

Tuesday, November 26, 2013 11:38 AM

The Boston Scientific Vercise Deep Brain Stimulation (DBS) System has received CE Mark approval for the treatment of intractable primary and secondary dystonia, a neurological movement disorder characterized by involuntary muscle contractions.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 18

Ebola outbreak highlights need to improve biosafety, infrastructure to handle future health emergencies

More African American professional women open to participating in medical research

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs